Early interventions for palliative care

Not Applicable

• Conditions: ater-stage respiratory disease and multi-morbidity late stages (COPD/multimorbidity) patients (and their carers and healthcare professionals (HCP); Respiratory

• Registration Number: ISRCTN24825698
• Lead Sponsor: HS Highland

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36271332/ (added 24/10/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-12-17
• Last Update Posted: 26 September 2023
• Study Completion: 2023-09-30

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 370

Inclusion Criteria

Current participant inclusion criteria as of 13/09/2023:
Patient:
1. Severe respiratory illness related to COPD or has respiratory disease as part of multimorbid state or has multi-morbid severe condition (Heart Failure etc)
2. Over the age of 55
3. Identified using the stratification model as being appropriate for receiving support / palliative care
4. Able to give written informed consent
5. Carer/HCP related to the patient participating also included as long as able to give written informed consent/adult

Previous participant inclusion criteria:
Patient:
1. Severe respiratory illness related to COPD or has respiratory disease as part of multimorbid state
2. Over the age of 55
3. Identified using the stratification model as being appropriate for receiving support / palliative care
4. Able to give written informed consent
5. Carer/HCP related to the patient participating also included as long as able to give written informed consent/adult

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> Current primary outcome measures as of 13/09/2023:<br> Stage One<br> Measured at baseline, 6 weeks, 6 months, 12 months and 18 months<br> 1. Quality of life (EQ-5D-5L)<br> 2. Intensity of symptoms (POS1/POS2)<br> 3. Functional status (PPSv2)<br><br><br><br><br> Previous primary outcome measures:<br> Stage One<br> Measured at baseline, 6 weeks, 6 months, 12 months and 18 months<br> 1. Quality of life (EQ-5D-5L)<br> 2. Intensity of symptoms (POS1/POS2)<br> 3. Functional status (PPSv2)<br><br> Stage 2<br> Measured at baseline, 6 weeks, 6 months, 12 months and 18 months<br> 1. Quality of life (EQ-5D-5L)<br> 2. Intensity of symptoms (POS1/POS2)<br> 3. Functional status (PPSv2)<br>